Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
U.S. Ski & Snowboard Names Dr. Thomas R. Hackett Chief Medical Officer
GlobeNewswire, Inc.
Vail, CO, Sept. 30, 2026 (GLOBE NEWSWIRE) -- U.S. Ski & Snowboard has announced the promotion of Thomas R. Hackett, M.D., to Chief Medical Officer (CMO). Dr. Hackett, a complex knee and shoulder surgeon at The Steadman Clinic and sports medicine...
Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial
GlobeNewswire, Inc.
The Phase I clinical trial will evaluate a proprietary drug candidate formulated using Cyprumed’s oral tablet technology, marking the first Cyprumed technology program to enter human clinical development The milestone triggers a payment to...
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
GlobeNewswire, Inc.
SAN DIEGO, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have...
Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026
GlobeNewswire, Inc.
SAN CARLOS, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need,...
Avaí Bio and Austrianova Present Encapsulated Cell Approach to Sustained α-Klotho Delivery at 2026 Klotho Conference
GlobeNewswire, Inc.
LAS VEGAS, NEVADA, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), together with joint venture partner Austrianova, today announced that Prof. Walter H. Günzburg presented the companies’ encapsulated-cell...
Coave Therapeutics to Present New Data on Wet AMD Gene Therapy Program at 26th Euretina Congress as it Advances towards the Clinic
GlobeNewswire, Inc.
Dr. Nora Dimon, VP of Clinical Development, to present preclinical findings on the Company’s lead retinal program, CoTx-101, including non-human primate data Rodolphe Clerval, CEO, to deliver a corporate presentation at the Euretina Innovation...
Cooling Solutions For Medical Equipment Market Forecast Report Featuring Segment Analysis And Strategic Industry Insight
EIN Presswire
The Business Research Company's Cooling Solutions For Medical Equipment Market Forecast Report Featuring Segment Analysis And Strategic Industry Insight LONDON, GREATER LONDON, UNITED KINGDOM, September 16, 2026 /EINPresswire.com/ -- "The demand...
Governor Meyer Signs Legislation Renaming Delaware Hospital in Honor of Eleanor Cain
Office of the Governor Delaware
FOR IMMEDIATE RELEASE Thursday, September 17, 2026 Media Contact: Jonah Anderson jonah.anderson@delaware.gov SMYRNA, Del. — Joined by state leaders, residents, staff, and members of the Cain family, Governor Matt Meyer today signed legislation...
AAVantgarde to Showcase Clinical Progress in Usher 1B and Stargardt Disease at EURetina 2026
GlobeNewswire, Inc.
MILAN, Sept. 16, 2026 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), the clinical-stage biotechnology company developing genetic medicines for inherited retinal diseases (IRDs) using its proprietary dual-AAV technology, today announced...
FemPulse Clinical Data to be Presented at ICS on October 9
GlobeNewswire, Inc.
VIENNA and SAN FRANCISCO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- FemPulse™, a bioelectronic medical technology company with first application overactive bladder (OAB), announced today that data from two recent clinical studies will be presented at the...
EURETINA: PulseSight Therapeutics to Present Results of Phase 1 clinical trial of PST-611 treatment for dry AMD/Geographic Atrophy (GA)
GlobeNewswire, Inc.
PARIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive non-viral vectorized gene therapies with minimally-invasive delivery technology, will be presenting the...
FROM JANE FONDA TO PRINCESS CHARLÈNE: MAKE‐UP ARTIST KARIM SATTAR JOINS MEDICAL BEAUTY RESEARCH
EIN Presswire
Make-up artist and skincare expert Karim Sattar joins MBR to lead creative artistry, celebrity relations and global brand visibility.
Egle Therapeutics to Present Clinical Data at the Upcoming European Academy of Dermatology and Venereology (EADV) Congress in Vienna
GlobeNewswire, Inc.
PARIS, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Egle Therapeutics (“Egle”), a clinical-stage biotechnology company advancing a proprietary therapeutic pipeline targeting T cell (Treg) modulation, announced that it will present new clinical data at the...
Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference
GlobeNewswire, Inc.
- Pasithea has been selected to present cutaneous neurofibromas (CN) clinical data in an oral presentation - Pasithea has been selected to present plexiform neurofibromas (PN) clinical data in a poster presentation - The European Neurofibromatosis...
Avaí Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for α-Klotho Anti-Aging Therapy
GlobeNewswire, Inc.
LAS VEGAS, NV, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-related disorders, and anti-aging, today...
Slick City and Activeon Accelerate European Expansion with New Parks in Sweden and Austria
GlobeNewswire, Inc.
CHESTERFIELD, Mo., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Slick City Franchise Group, the world’s first indoor slide and air court franchise, today announced plans to open new locations in Gothenburg, Sweden and Vienna, Austria, as the brand continues...
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
GlobeNewswire, Inc.
FREMONT, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- As clinical laboratories seek deeper cellular insights, greater efficiency, and more streamlined approaches to cell analysis, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB)...
F2G Announces Posters Accepted for Presentation at Upcoming Medical Meetings
GlobeNewswire, Inc.
MANCHESTER, United Kingdom, Sept. 01, 2026 (GLOBE NEWSWIRE) -- F2G Ltd., today announced abstracts accepted for presentation at the MSGERC 2026 Biennial Meeting in September and ISPOR Europe 2026 in November.
Sole Searching: Why Foot Health May Be Wellness’s Next Longevity Frontier
EIN Presswire
Hotels and retreats worldwide are putting the feet front and center, as new research ties foot and lower-leg strength to healthy aging.
Nutrition May Help Support Nerve Health Alongside Diabetes Management, Specialists Say
EIN Presswire
Diabetic Nerve Clinic encourages patients to view healthy eating as part of a comprehensive approach to protecting nerve function.
Sign up for:
Austria Health Focus
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.